Grönroos T - Search Results

1

Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing.

Bentzen L, Keiding S, Horsman MR, Grönroos T, Hansen SB, Overgaard J. Bentzen L, et al. Among authors: gronroos t. Acta Oncol. 2002;41(3):304-12. doi: 10.1080/02841860260088863. Acta Oncol. 2002. PMID: 12195751

2

Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.

Grönroos T, Bentzen L, Marjamäki P, Murata R, Horsman MR, Keiding S, Eskola O, Haaparanta M, Minn H, Solin O. Grönroos T, et al. Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):513-20. doi: 10.1007/s00259-003-1404-x. Epub 2004 Jan 14. Eur J Nucl Med Mol Imaging. 2004. PMID: 14722675

3

Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio.

Lehtiö K, Oikonen V, Nyman S, Grönroos T, Roivainen A, Eskola O, Minn H. Lehtiö K, et al. Among authors: gronroos t. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):101-8. doi: 10.1007/s00259-002-1016-x. Epub 2002 Oct 30. Eur J Nucl Med Mol Imaging. 2003. PMID: 12483416 Clinical Trial.

4

Repeatability of tumour hypoxia imaging using [¹⁸F]EF5 PET/CT in head and neck cancer.

Silvoniemi A, Suilamo S, Laitinen T, Forsback S, Löyttyniemi E, Vaittinen S, Saunavaara V, Solin O, Grönroos TJ, Minn H. Silvoniemi A, et al. Among authors: gronroos tj. Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):161-169. doi: 10.1007/s00259-017-3857-3. Epub 2017 Oct 26. Eur J Nucl Med Mol Imaging. 2018. PMID: 29075831 Free PMC article. Clinical Trial.

5

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.

Lehtiö K, Eskola O, Viljanen T, Oikonen V, Grönroos T, Sillanmäki L, Grénman R, Minn H. Lehtiö K, et al. Among authors: gronroos t. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):971-82. doi: 10.1016/j.ijrobp.2003.12.014. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234030

6

Pharmacokinetics of [18F]FETNIM: a potential marker for PET.

Grönroos T, Eskola O, Lehtiö K, Minn H, Marjamäki P, Bergman J, Haaparanta M, Forsback S, Solin O. Grönroos T, et al. J Nucl Med. 2001 Sep;42(9):1397-404. J Nucl Med. 2001. PMID: 11535732 Free article.

7

18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.

Komar G, Seppänen M, Eskola O, Lindholm P, Grönroos TJ, Forsback S, Sipilä H, Evans SM, Solin O, Minn H. Komar G, et al. J Nucl Med. 2008 Dec;49(12):1944-51. doi: 10.2967/jnumed.108.053785. Epub 2008 Nov 7. J Nucl Med. 2008. PMID: 18997048 Free article.

8

Evaluation of [¹⁸F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy.

Tuominen S, Keller T, Petruk N, López-Picón F, Eichin D, Löyttyniemi E, Verhassel A, Rajander J, Sandholm J, Tuomela J, Grönroos TJ. Tuominen S, et al. Among authors: gronroos tj. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1312-1326. doi: 10.1007/s00259-020-05115-z. Epub 2020 Dec 19. Eur J Nucl Med Mol Imaging. 2021. PMID: 33340054 Free PMC article.

9

Imaging of tumor hypoxia to predict treatment sensitivity.

Minn H, Grönroos TJ, Komar G, Eskola O, Lehtiö K, Tuomela J, Seppänen M, Solin O. Minn H, et al. Among authors: gronroos tj. Curr Pharm Des. 2008;14(28):2932-42. doi: 10.2174/138161208786404380. Curr Pharm Des. 2008. PMID: 18991711 Review.

10

Nodal staging of lymphoma with whole-body PET: comparison of.

Sutinen E, Jyrkkiö S, Varpula M, Lindholm P, Grönroos T, Lehikoinen P, Teräs M, Minn H. Sutinen E, et al. Among authors: gronroos t. J Nucl Med. 2000 Dec;41(12):1980-8. J Nucl Med. 2000. PMID: 11138682 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page